PUNIT DHILLON

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PUNIT DHILLON:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Chief Executive Officer, Director Common Stock 330K $1.65M $4.99 18 Nov 2024 Direct
Skye Bioscience, Inc. Chief Executive Officer, Director Common Stock 9.34K $46.6K $4.99 15 Nov 2024 Trust
Arch Therapeutics, Inc. Director Stock Option (right to buy) 250K 10 Nov 2022 Direct
Skye Bioscience, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 250K 24 Feb 2025 Direct

Insider Reports Filed by PUNIT DHILLON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 24 Feb 2025 1 $0 4 Chief Executive Officer, Director 26 Feb 2025, 17:43
SKYE Skye Bioscience, Inc. 15 Nov 2024 2 -$414K 4 Chief Executive Officer, Director 19 Nov 2024, 21:20
SKYE Skye Bioscience, Inc. 28 Oct 2024 1 $0 4 Chief Executive Officer, Director 30 Oct 2024, 20:31
SKYE Skye Bioscience, Inc. 26 Aug 2024 1 $0 4 Chief Executive Officer, Director 27 Aug 2024, 17:20
SKYE Skye Bioscience, Inc. 29 Feb 2024 2 $0 4/A Chief Executive Officer, Director 04 Mar 2024, 06:13
SKYE Skye Bioscience, Inc. 29 Feb 2024 2 $0 4 Chief Executive Officer, Director 01 Mar 2024, 18:24
SKYE Skye Bioscience, Inc. 06 Nov 2023 2 $0 4 Chief Executive Officer, Director 06 Nov 2023, 20:29
SKYE Skye Bioscience, Inc. 25 Aug 2023 5 $18.5K 4/A Chief Executive Officer, Director 31 Aug 2023, 11:26
SKYE Skye Bioscience, Inc. 10 Nov 2022 6 $0 4 Chief Executive Officer, Director 15 Nov 2022, 12:41
ARTH Arch Therapeutics, Inc. 10 Nov 2022 1 $0 4 Director 10 Nov 2022, 20:54
SKYE Skye Bioscience, Inc. 14 Dec 2021 2 $0 4 Chief Executive Officer, Director 16 Dec 2021, 18:03
ARTH Arch Therapeutics, Inc. 27 Sep 2021 2 $0 4 Director 01 Oct 2021, 08:11